Through the use of artificial intelligence and concepts including machine and deep learning, the life sciences sector is seeing unprecedented levels of speed and efficiency in finding new drug candidates and pushing them towards commercialization. Yet integrating the complexity of AI and big data into healthcare still presents problems and challenges whether from a financing point of view or operationally.